Frequently Asked Questions
Real Answers From Your Physician-Led Weight Loss Team
At TOM Weight Loss, your care is led by a board-certified obesity medicine physician, your pricing is published openly, and your medication is delivered to your door. Here are the questions our patients ask us most.
About TOM
Real care, not just a prescription
A quick look at who we are, where we work, and how care happens for every patient.
TOM Weight Loss (Texas Obesity Medicine) is a Houston-based telehealth clinic that treats obesity as a chronic disease, with care led by a board-certified obesity medicine physician.
We see patients across Texas and Utah, all by telehealth.
Our team is headquartered in Houston at 5373 W. Alabama St. #204, Houston, TX 77056, though every patient visit is virtual.
Your care is led by Dr. Le, our board-certified obesity medicine physician — a doctor specifically trained and certified in the medical treatment of obesity.
You get a direct relationship with a board-certified obesity medicine physician, transparent published pricing
, and medications delivered to your door — concierge-level care without the concierge price tag.
Visit our Get Started page
, complete a short health intake, and book your first telehealth visit with your physician.
Every patient receives a telehealth consultation with a board-certified obesity medicine physician, a personalized care plan, GLP-1 medication management when appropriate, ongoing physician follow-ups, and home delivery of medication — all under transparent, flat-rate pricing. See what's included.
Pricing
Everything included, nothing hidden
Our pricing is published openly so you can decide on your terms. No insurance claims, no surprises.
TOM offers two flat-rate, all-inclusive monthly memberships: Basic at $199/month(compounded semaglutide up to 2.4 mg per week) and Premium at $249/month(compounded tirzepatide up to 15 mg per week, or compounded semaglutide above 2.4 mg up to 7.2 mg per week). Both include your physician, monitoring, and home delivery — see the full breakdown on our Transparent Pricing page.
Your membership covers your prescribed medication, a personalized treatment plan, direct access to your board-certified obesity medicine physician, ongoing medical monitoring and dose adjustments, prescription management, and 24/7 access to medical guidance — all delivered to your door.
TOM doesn't take insurance, which is how we're able to keep pricing transparent and predictable for every patient. Your monthly membership covers everything — medication, physician access, and ongoing care — with no claims, copays, or surprise bills. We accept HSA and FSA payments.
None. Your monthly price is all-inclusive — medication, physician visits, ongoing care, and home delivery are all covered, and what you see on our Transparent Pricing page
is exactly what you pay.
Basic ($199/month)
covers compounded semaglutide up to 2.4 mg per week, ideal for patients beginning GLP-1 therapy or looking for a steady, lower-cost option. Premium ($249/month)
covers compounded tirzepatide up to 15 mg per week (or higher-dose compounded semaglutide up to 7.2 mg per week), for patients who may benefit from dual GLP-1 + GIP therapy or higher dosing. Both plans include the same level of physician-led care.
GLP-1 medications
Understanding GLP-1 care
How this class of medication works, what to expect, and who it's for.
GLP-1 (glucagon-like peptide-1) is a natural hormone your body produces. GLP-1 medications are prescription medications that mimic that hormone to help regulate appetite, fullness, and blood sugar.
GLP-1 medications help you feel full sooner and longer, slow how quickly food leaves your stomach, and steady your blood sugar response, making it easier to eat less without feeling constantly hungry.
The most common side effects are gastrointestinal — nausea, vomiting, diarrhea, or constipation — and tend to ease as your body adjusts. Rare but more serious risks like pancreatitis or gallbladder issues are why ongoing physician oversight matters.
There isn't one "best" GLP-1; the right one depends on your medical history, tolerance, and goals, and your physician will guide that decision with you. In clinical studies, tirzepatide has shown greater average weight reduction than semaglutide
, but the right choice is patient-specific.
GLP-1 medications are generally appropriate for adults with a BMI in the obesity range, or in the overweight range with related health conditions, though final eligibility is a medical decision your physician makes after reviewing your history. Complete a short intake
to find out if you're a candidate.
Semaglutide
About semaglutide
The single-pathway GLP-1 medication included in our Basic membership.
Semaglutide is a prescription GLP-1 medication used for weight management and type 2 diabetes. It's the active ingredient in Ozempic and Wegovy.
Semaglutide mimics the GLP-1 hormone to help you feel full sooner, slow stomach emptying, and steady your blood sugar. It's typically given as a once-weekly injection, started at a low dose and gradually increased.
The most common are gastrointestinal — nausea, vomiting, diarrhea, and constipation — usually strongest when starting or increasing a dose. Rarer serious risks include pancreatitis, gallbladder issues, and kidney concerns.
For most patients, the common side effects are strongest in the first few days to weeks of starting or after a dose increase, then ease as the body adjusts. Persistent or severe symptoms should always be reported to your physician.
Tirzepatide
About tirzepatide
The dual-pathway medication included in our Premium membership.
Tirzepatide is a prescription injectable medication used for weight management and type 2 diabetes. It's the active ingredient in Mounjaro and Zepbound.
Tirzepatide activates two hormone pathways — GLP-1 and GIP — to help you feel full longer, reduce cravings, and steady your blood sugar. It's given as a once-weekly injection, started at a low dose.
The most common are gastrointestinal — nausea, vomiting, diarrhea, constipation, and decreased appetite — usually strongest at the start or after a dose increase. Rarer serious risks include pancreatitis, gallbladder issues, and kidney concerns.
Semaglutide vs. tirzepatide
Two medications, one decision
Two excellent medications with different mechanisms. Which is right for you is a conversation with your physician.
Semaglutide
activates one hormone pathway (GLP-1), while tirzepatide
activates two (GLP-1 and GIP). In clinical studies, tirzepatide has shown greater average weight reduction, but the right choice depends on your medical history, tolerance, and goals.
What to expect long-term
Obesity is a chronic disease
How we think about the long view — and what it means for your care plan.
Not necessarily, but obesity is a chronic disease — like high blood pressure or type 2 diabetes — and most patients benefit from long-term medical management to maintain their results. Whether you continue, taper, or eventually stop is a decision you'll make with your physician based on your progress, health, and goals.
Because GLP-1 medications work while they're being taken, many patients experience some weight regain after stopping, especially without ongoing medical and lifestyle support. That's why we treat obesity as a chronic disease and plan for the long term — any decision to taper or stop is made with your physician, so it's done safely and with a clear plan in place.
Ready when you are
Your weight loss journey starts today
Work with a board-certified obesity medicine physician, enjoy transparent pricing, and have medication delivered directly to your door. Have more questions? Our team is here to help whenever you’re ready to take the next step.
This page is for general informational purposes only and is not a substitute for personalized medical advice. Eligibility, treatment decisions, and dosing are determined by your physician based on your individual health history. Always speak with your TOM physician about any questions or concerns regarding your care.
